Researchers have developed a simple, robust blood test that accurately measures type 1 diabetes-related autoimmunity using minimal blood volumes, making it particularly suitable for paediatric patients. Called BASTA (β cell antigen-specific T cell assay), this test captures CD4+ T cell responses to pancreatic beta cells, offering an improved method to track autoimmune responses in both […]
A comprehensive analysis of early-onset type 2 diabetes (T2D) in China reveals the age-standardised incidence rate has more than doubled between 1990 and 2021, highlighting an urgent public health challenge. The study, published in Health Data Science in December 2024, found particularly concerning trends among adolescents and young males.
Researchers have developed a new treatment approach for type 2 diabetes that could potentially eliminate the need for insulin therapy in a majority of patients, according to findings presented at UEG Week 2024 in Vienna.
Advancements in glucose monitoring and insulin delivery systems are enabling people with type 1 diabetes to participate in demanding physical activities, while fear of hypoglycaemia remains a significant barrier to exercise for many.
April 2024
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
Siyan Zhan, Peking University